Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway

REFERENCES

• Andreassen, P. R., A. D. D'Andrea, and T. Taniguchi. 2004. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18:1958–1963.
   PubMed Web of Science ®Google Scholar
• Auerbach, A. D. 1993. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp. Hematol. 21:731–733.
   PubMed Web of Science ®Google Scholar
• de Winter, J. P., F. Leveille, C. G. van Berkel, M. A. Rooimans, L. van DerWeel, J. Steltenpool, I. Demuth, N. V. Morgan, N. Alon, L. Bosnoyan-Collins, J. Lightfoot, P. A. Leegwater, Q. Waisfisz, K. Komatsu, F. Arwert, J. C. Pronk, C. G. Mathew, M. Digweed, M. Buchwald, and H. Joenje. 2000. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67:1306–1308.
   PubMed Web of Science ®Google Scholar
• Dunn, J., M. Potter, A. Rees, and T. M. Runger. 2006. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light. Cancer Res. 66:11140–11147.
   PubMedGoogle Scholar
• Garcia-Higuera, I., T. Taniguchi, S. Ganesan, M. S. Meyn, C. Timmers, J. Hejna, M. Grompe, and A. D. D'Andrea. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7:249–262.
   PubMed Web of Science ®Google Scholar
• Ho, G., S. Margossian, T. Taniguchi, and A. D. D'Andrea. 2006. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell. Biol. 26:7005–7015.
   PubMed Web of Science ®Google Scholar
• Houghtaling, S., C. Timmers, M. Noll, M. Finegold, S. Jones, M. S. Meyn, and M. Grompe. 2003. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17:2021–2035.
   PubMedGoogle Scholar
• Jin, J., T. Shirogane, L. Xu, G. Nalepa, J. Qin, S. J. Elledge, and J. W. Harper. 2003. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17:3062–3074.
   PubMed Web of Science ®Google Scholar
• Jin, Y., M. S. Dai, S. Z. Lu, Y. Xu, Z. Luo, Y. Zhao, and H. Lu. 2006. 14-3-3γ Binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J. 25:1207–1218.
   PubMedGoogle Scholar
• Joenje, H., and K. J. Patel. 2001. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2:446–457.
   PubMed Web of Science ®Google Scholar
• Kennedy, R. D., and A. D. D'Andrea. 2005. The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev. 19:2925–2940.
   PubMed Web of Science ®Google Scholar
• Kohn, E. A., C. J. Yoo, and A. Eastman. 2003. The protein kinase C inhibitor Go6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints. Cancer Res. 63:31–35.
   PubMed Web of Science ®Google Scholar
• Lin, S. Y., K. Li, G. S. Stewart, and S. J. Elledge. 2004. Human claspin works with BRCA1 to both positively and negatively regulate cell proliferation. Proc. Natl. Acad. Sci. USA 101:6484–6489.
   PubMed Web of Science ®Google Scholar
• Machida, Y. J., Y. Machida, Y. Chen, A. M. Gurtan, G. M. Kupfer, A. D. D'Andrea, and A. Dutta. 2006. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23:589–596.
   PubMed Web of Science ®Google Scholar
• Mack, P. C., D. R. Gandara, A. H. Lau, P. N. Lara, Jr., M. J. Edelman, and P. H. Gumerlock. 2003. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma. Cancer Chemother. Pharmacol. 51:337–348.
   PubMedGoogle Scholar
• Mailand, N., J. Falck, C. Lukas, R. G. Syljuasen, M. Welcker, J. Bartek, and J. Lukas. 2000. Rapid destruction of human Cdc25A in response to DNA damage. Science 288:1425–1429.
   PubMed Web of Science ®Google Scholar
• Manke, I. A., A. Nguyen, D. Lim, M. Q. Stewart, A. E. Elia, and M. B. Yaffe. 2005. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17:37–48.
   PubMed Web of Science ®Google Scholar
• Matsushita, N., H. Kitao, M. Ishiai, N. Nagashima, S. Hirano, K. Okawa, T. Ohta, D. S. Yu, P. J. McHugh, I. D. Hickson, A. R. Venkitaraman, H. Kurumizaka, and M. Takata. 2005. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19:841–847.
   PubMedGoogle Scholar
• Meetei, A. R., J. P. de Winter, A. L. Medhurst, M. Wallisch, Q. Waisfisz, H. J. van de Vrugt, A. B. Oostra, Z. Yan, C. Ling, C. E. Bishop, M. E. Hoatlin, H. Joenje, and W. Wang. 2003. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35:165–170.
   PubMed Web of Science ®Google Scholar
• Meetei, A. R., A. L. Medhurst, C. Ling, Y. Xue, T. R. Singh, P. Bier, J. Steltenpool, S. Stone, I. Dokal, C. G. Mathew, M. Hoatlin, H. Joenje, J. P. de Winter, and W. Wang. 2005. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37:958–963.
   PubMed Web of Science ®Google Scholar
• Mosedale, G., W. Niedzwiedz, A. Alpi, F. Perrina, J. B. Pereira-Leal, M. Johnson, F. Langevin, P. Pace, and K. J. Patel. 2005. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12:763–771.
   PubMed Web of Science ®Google Scholar
• Niedernhofer, L. J., A. S. Lalai, and J. H. Hoeijmakers. 2005. Fanconi anemia (cross)linked to DNA repair. Cell 123:1191–1198.
   PubMed Web of Science ®Google Scholar
• O'Neill, T., L. Giarratani, P. Chen, L. Iyer, C. H. Lee, M. Bobiak, F. Kanai, B. B. Zhou, J. H. Chung, and G. A. Rathbun. 2002. Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J. Biol. Chem. 277:16102–16115.
   PubMed Web of Science ®Google Scholar
• Ory, D. S., B. A. Neugeboren, and R. C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93:11400–11406.
   PubMed Web of Science ®Google Scholar
• Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms, and S. J. Elledge. 1997. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277:1497–1501.
   PubMed Web of Science ®Google Scholar
• Sorensen, C. S., L. T. Hansen, J. Dziegielewski, R. G. Syljuasen, C. Lundin, J. Bartek, and T. Helleday. 2005. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell Biol. 7:195–201.
   PubMed Web of Science ®Google Scholar
• Taniguchi, T., and A. D. D'Andrea. 2002. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 100:2457–2462.
   PubMed Web of Science ®Google Scholar
• Taniguchi, T., I. Garcia-Higuera, P. R. Andreassen, R. C. Gregory, M. Grompe, and A. D. D'Andrea. 2002. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100:2414–2420.
   PubMed Web of Science ®Google Scholar
• Wang, X., P. R. Andreassen, and A. D. D'Andrea. 2004. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24:5850–5862.
   PubMed Web of Science ®Google Scholar
• Xu, B., S. Kim, and M. B. Kastan. 2001. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21:3445–3450.
   PubMed Web of Science ®Google Scholar
• Yarden, R. I., S. Pardo-Reoyo, M. Sgagias, K. H. Cowan, and L. C. Brody. 2002. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30:285–289.
   PubMed Web of Science ®Google Scholar
• Zhao, H., and H. Piwnica-Worms. 2001. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21:4129–4139.
   PubMed Web of Science ®Google Scholar